As an established leader in the field of
Hematology/Oncology, Mari leverages her expertise
treating liquid tumors in her current position as
Associate Vice President at Eli Lilly where she leads
a late-stage Malignant Hematology
program. Additionally, Mari is deeply committed to
promoting diversity initiatives and helping drive
positive change within the organization. She
completed her training at MD Anderson Cancer
Center in 2005 and subsequently obtained an MS in
Clinical Research at UT and an MBA at Imperial
College, London. She is a South Florida native who
speaks fluent Spanish and understands the culture
and the local healthcare landscape.
Daniel Paull MD explains why he thinks that despite what the public thinks, most physicians are unhappy.